AR041131A1 - Derivados de aminoindazol utilizados como medicamentos y composiciones farmaceuticas que los contienen - Google Patents
Derivados de aminoindazol utilizados como medicamentos y composiciones farmaceuticas que los contienenInfo
- Publication number
- AR041131A1 AR041131A1 ARP030103186A ARP030103186A AR041131A1 AR 041131 A1 AR041131 A1 AR 041131A1 AR P030103186 A ARP030103186 A AR P030103186A AR P030103186 A ARP030103186 A AR P030103186A AR 041131 A1 AR041131 A1 AR 041131A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- nhc
- nr10r11
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicación 1: Los compuestos de la fórmula (1), en la cual: R3 es un radical alquilo (C1-6), arilo, aril-alquilo (C1-6), heteroarilo, heteroaril-alquilo (C1-6), arilo o heteroarilo condensado con un cicloalquilo(C1-10), heterociclo, heterocicloalquilo, cicloalquilo, adamantilo, policicloalquilos, alquenilo, alquinilo, CONR1R2, CSNR1R2, CSNR1R2, COOR1, SO2R1, C(=NH)R1, C(=NH)NR1; estando estos radicales eventualmente sustituidos con 1 a varios sustituyentes elegidos entre halógeno, CN, NO2, NH2, OH, OR1, COOH, C(O)OR1, -O-C(O)R1, NR1R2, NH(O)R1, C(O)NR1R2, SR1, S(O)R1, SO2R1, NHSO2R1, SO2NR1R2, C(S)NR1R2, NHC(S)R1, -O-SO2-R1, -SO2-O-R1, arilo, heteroarilo, heterociclo, formilo, trifluorometilo, trifluorometilsulfanilo, trifluorometoxi, alquilo (C1-6); R5, R6 se eligen independientemente uno de otro entre los radicales siguientes, halógeno, CN, NO2, NH2, OH, COOH, C(O)OR8, -O-C(O)R8, NR8R9, NHC(O)R8, C(O)NR8R9, NHC(S)R8, C(S)NR8R9, SR8, S(O)R8, SO2R8, NHSO2R8, SO2R8R9, -O-SO2R8, -SO2-O-R8, trifluorometilo, trifluorometoxi, alquilo (C1-6), alcoxi (C1-6), arilo, aril-alquilo (C1-6), heteroarilo, heteroaril-alquilo (C1-6), heterociclo, cicloalquilo, alquenilo, alquinilo, adamantilo, policicloalquilos; estando estos radicales eventualmente sustituidos con 1 o varios sustituyentes elegidos entre halógeno, CN, NO2, NH2, OH, OR10, COOH, C(O)OR10, -O-C(O)R10, NR10R11, NHC(O)R10, C(O)NR10R11, NHC(S)R10, C(S)NR10R11, SR10, S(O)R10, SO2R10, NHSO2R10, SO2NR10R11, -O-SO2R10, -SO2-O-R10, arilo, heteroarilo, formilo, trifluorometilo, trifluorometoxi, alquilo (C1-6); R1, R2, R8, R9, R10, R11 son independientemente uno de otro, un hidrógeno, alquilo (C1-6), arilo, alquenilo, alquinilo, heteroarilo, estando ellos mismos eventualmente sustituidos con 1 o varios sustituyentes elegidos entre halógeno, alquilo (C1-6), alcoxi (C1-6), CN, NO2, NH2, OH, COOH, COOalquilo, CONH2, formilo, trifluorometilo, trifluorometoxi; R1 y R2 o R8 y R9 o R10 y R11 pueden formar un ciclo de 5 ó 6 miembros que tiene o no un heteroátomo tal como O, S, N; y cuando R3 es un heteroarilo nitrogenado de 6 miembros o un tiazolilo o un imidazolilo o un oxazolilo, entonces al menos uno de los R5, R6, es un anillo que está eventualmente sustituido con 1 o varios sustituyentes elegidos entre halógeno, CN, NO2, NH2, OH, OR10, COOH, C(O)OR10, -O-C(O)R10, NR10R11, NHC(O)R10, C(O)NR10R11, NHC(S)R10, C(S)NR10R11, SR10, S(O)R10, SO2R10, NHSO2R10, SO2NR10R11, -O-SO2R10, -SO2-O-R10, arilo, heteroarilo, formilo trifluorometilo, trifluorometoxi, alquilo (C1-6); sus racémicos, enantiómeros, diastereoisómeros y sus mezclas, sus tautómeros y sus sales farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0210962A FR2844267B1 (fr) | 2002-09-05 | 2002-09-05 | Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant |
Publications (1)
Publication Number | Publication Date |
---|---|
AR041131A1 true AR041131A1 (es) | 2005-05-04 |
Family
ID=31725841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030103186A AR041131A1 (es) | 2002-09-05 | 2003-09-03 | Derivados de aminoindazol utilizados como medicamentos y composiciones farmaceuticas que los contienen |
Country Status (9)
Country | Link |
---|---|
CN (1) | CN1982316A (es) |
AR (1) | AR041131A1 (es) |
FR (1) | FR2844267B1 (es) |
ME (1) | MEP25708A (es) |
MY (1) | MY146796A (es) |
PE (1) | PE20040995A1 (es) |
RS (1) | RS52767B (es) |
TW (2) | TWI353245B (es) |
ZA (1) | ZA200501427B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007002717A1 (de) | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Heterocyclische Indazolderivate |
DE102007022565A1 (de) | 2007-05-14 | 2008-11-20 | Merck Patent Gmbh | Heterocyclische Indazolderivate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638926B2 (en) * | 2000-09-15 | 2003-10-28 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
CN100436452C (zh) * | 2000-12-21 | 2008-11-26 | 沃泰克斯药物股份有限公司 | 可用作蛋白激酶抑制剂的吡唑化合物 |
-
2002
- 2002-09-05 FR FR0210962A patent/FR2844267B1/fr not_active Expired - Fee Related
-
2003
- 2003-09-01 PE PE2003000885A patent/PE20040995A1/es not_active Application Discontinuation
- 2003-09-03 ME MEP-257/08A patent/MEP25708A/xx unknown
- 2003-09-03 AR ARP030103186A patent/AR041131A1/es unknown
- 2003-09-03 CN CNA2007100042108A patent/CN1982316A/zh active Pending
- 2003-09-03 RS YU20050165A patent/RS52767B/sr unknown
- 2003-09-04 TW TW096144479A patent/TWI353245B/zh not_active IP Right Cessation
- 2003-09-04 MY MYPI20033345A patent/MY146796A/en unknown
- 2003-09-04 TW TW092124408A patent/TWI353978B/zh not_active IP Right Cessation
-
2005
- 2005-02-17 ZA ZA200501427A patent/ZA200501427B/en unknown
Also Published As
Publication number | Publication date |
---|---|
TWI353978B (en) | 2011-12-11 |
ZA200501427B (en) | 2006-04-26 |
TW200820967A (en) | 2008-05-16 |
CN1982316A (zh) | 2007-06-20 |
RS52767B (sr) | 2013-10-31 |
TWI353245B (en) | 2011-12-01 |
PE20040995A1 (es) | 2005-01-28 |
FR2844267A1 (fr) | 2004-03-12 |
MY146796A (en) | 2012-09-28 |
TW200413325A (en) | 2004-08-01 |
RS20050165A (en) | 2007-08-03 |
FR2844267B1 (fr) | 2008-02-15 |
MEP25708A (en) | 2010-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR038915A1 (es) | Derivados de aminoindazoles, procedimiento de preparacion e intermedios de este procedimiento, medicamentos y composiciones farmaceuticas que contienen al compuesto | |
AR079541A1 (es) | Compuestos sustituidos de n-(1h-indazol-4-il) imidazo (1,2-a) piridin-3-carboxamida como inhibidores de cfms | |
AR025975A1 (es) | Compuestos quimicos. | |
HUP0402376A2 (hu) | Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények | |
AR058769A1 (es) | Inhibidores de peptidil-deformilasa(pdf),utiles para el tratamiento de la tuberculosis y composiciones farmaceuticas que los contienen. | |
AR039933A1 (es) | Indoles sustituidos para tratamiento de desordenes respiratorios | |
AR049739A1 (es) | Derivados de aril-piridina | |
BR0314098A (pt) | Derivados da aminoindazóis a tìtulo de medicamentos e composições farmacêuticas que os contêm | |
AR045462A1 (es) | DERIVADOS DE INDOLES SUSTITUIDOS eTILES COMO COMPUESTOS FARMACEUTICOS PARA EL TRATAMIENTO DE ENFERMEDADES RESPIRATORIAS | |
AR064258A1 (es) | Inhibidores macrociclicos del virus de hepatitis c | |
HUP0303652A2 (hu) | Ciklikus származékok, mint kemokin receptor aktivitás modulátorai és ezeket tartalmazó gyógyszerkészítmények | |
CO5280046A1 (es) | Agonistas alfa 7 y sus composiciones farmaceuticas | |
AR039403A1 (es) | Derivados de acil-4-carboxifenilurea y su uso como antidiabetico | |
HUP0301113A2 (hu) | Pirrolidinszármazékok, mint ciklusos amp-specifikus foszfodiészteráz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0402529A2 (hu) | Xa faktor és más, a koagulációs kaszkádban részt vevő szerin-proteázok inhibitorai, eljárás előállításukra és ezeket hatóanyagként tartalmazó gyógyszerkészítmények | |
CO5690588A2 (es) | Derivados de 4-tetrazolilo-4 fenilpiperidina para el trata- miento del dolor | |
AR042024A1 (es) | Compuestos farmaceuticos derivados de piridona, pirimidona y pirazinona | |
AR044552A1 (es) | Derivados del indol,composiciones farmaceuticas que los contienen y procesos para su preparacion, de utilidad para el tratamiento de trastornos respiratorios | |
HUP0402454A2 (hu) | Szubsztituált kinazolinszármazékok mint az aurora kinázok inhibitorai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0201988A2 (hu) | N-(indolkarbonil)piperazin-származékok | |
ATE455119T1 (de) | Thiazolo-, oxazalo und imidazolo- chinazolinverbindungen, die dazu fähig sind, proteinkinasen zu hemmen | |
CO5031253A1 (es) | Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen | |
AR039934A1 (es) | Indoles sustituidos para el tratamiento de desordenes respiratorios | |
MXPA03010584A (es) | Derivados de tiazol u oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas. | |
CO5601012A2 (es) | Compuestos que modulan la actividad de ppar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |